EFL033 - GLP-1 Receptor Agonists and SGLT2 Inhibitors in Type 1 Diabetes [keto gummies with acv]

EFL033 - GLP-1 Receptor Agonists and SGLT2 Inhibitors in Type 1 Diabetes [keto gummies with acv]

| 1h 28m 28s | Video has closed captioning.

Join host Chase Hendrickson, MD, from Vanderbilt University Medical Center as he discusses an article in The Journal of Clinical Endocrinology & Metabolism with Ashok Balasubramanyam, MD, from Baylor College of Medicine and guest expert David Nathan, MD, from Harvard Medical School and Massachusetts General Hospital. The featured article, by Edwards et al, was first published online in October 2022 in JCEM: “Clinical and Safety Outcomes With GLP-1 Receptor Agonists and SGLT2 Inhibitors in Type 1 Diabetes: A Real-World Study.” For more information, including helpful links and other episodes, visit our website at